Envista (NYSE:NVST) Cut to Buy at Wall Street Zen

Wall Street Zen downgraded shares of Envista (NYSE:NVST) from a strong-buy rating to a buy rating in a research report report published on Saturday morning,Wall Street Zen reports.

Several other research analysts have also commented on NVST. Deutsche Bank Aktiengesellschaft set a $32.00 price target on shares of Envista in a research note on Thursday. BMO Capital Markets initiated coverage on shares of Envista in a report on Wednesday, July 8th. They issued a “market perform” rating and a $27.00 price objective for the company. Zacks Research raised shares of Envista from a “hold” rating to a “strong-buy” rating in a research report on Friday, August 7th. Robert W. Baird set a $34.00 target price on Envista in a report on Thursday, August 6th. Finally, Piper Sandler reaffirmed a “neutral” rating and issued a $28.00 price target (up from $26.00) on shares of Envista in a research report on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $29.71.

Envista Stock Down 0.6%

Shares of Envista stock opened at $27.12 on Friday. The firm has a market cap of $4.36 billion, a price-to-earnings ratio of 46.76, a P/E/G ratio of 1.30 and a beta of 0.86. The stock has a 50-day simple moving average of $27.23 and a 200-day simple moving average of $26.27. Envista has a 52-week low of $18.77 and a 52-week high of $30.42. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.43 and a quick ratio of 2.07.

Envista (NYSE:NVST) last released its quarterly earnings data on Wednesday, August 5th. The company reported $0.41 EPS for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. The firm had revenue of $730.50 million for the quarter, compared to the consensus estimate of $716.11 million. Envista had a return on equity of 7.88% and a net margin of 3.33%.The firm’s revenue was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.26 earnings per share. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. On average, equities research analysts expect that Envista will post 1.53 earnings per share for the current fiscal year.

Insider Transactions at Envista

In other Envista news, SVP Mischa Reis sold 8,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $27.50, for a total value of $220,000.00. Following the sale, the senior vice president owned 27,321 shares of the company’s stock, valued at $751,327.50. This trade represents a 22.65% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.99% of the stock is owned by company insiders.

Hedge Funds Weigh In On Envista

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. California State Teachers Retirement System boosted its holdings in shares of Envista by 2,460.3% in the 2nd quarter. California State Teachers Retirement System now owns 4,972,429 shares of the company’s stock worth $131,024,000 after acquiring an additional 4,778,217 shares in the last quarter. Millennium Management LLC increased its holdings in Envista by 1,442.7% during the 4th quarter. Millennium Management LLC now owns 2,420,615 shares of the company’s stock valued at $52,552,000 after purchasing an additional 2,263,712 shares in the last quarter. Holocene Advisors LP acquired a new stake in Envista during the 2nd quarter valued at $43,936,000. Arrowstreet Capital Limited Partnership raised its position in Envista by 341.5% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,858,293 shares of the company’s stock valued at $72,515,000 after purchasing an additional 2,210,847 shares during the last quarter. Finally, Norges Bank bought a new position in Envista in the 4th quarter valued at $45,113,000.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.